Testing effectiveness (Phase 2)Study completedNCT02172768
What this trial is testing
Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease
Who this might be right for
Acute Graft Versus Host Disease Grade II-IVAllogeneic Stem Cell TransplantAcute Myeloid Leucaemia+1 more
Radboud University Medical Center 30